Nghi Nguyen

Nghi Nguyen Email and Phone Number

Vice President, Corporate Development at AnaptysBio @ AnaptysBio
Nghi Nguyen's Location
San Francisco Bay Area, United States, United States
About Nghi Nguyen

I joined AnaptysBio as its VP of Corporate Development from Medkine and Ascendis Pharma where I was Head of Corporate Development and Head of BD and Alliance Management, respectively. Prior to Ascendis, I supported Corporate Development under Jung Choi at Global Blood Therapeutics (acquired by Pfizer for $5.4B) for almost five years. Before moving in-house, I spent some time in healthcare investment banking at Wedbush Securities and gained investing and operating experience at The L’Oreal Group in its Global Technology Incubator.I was trained as a scientist. From 2004 to 2010, I worked in six different laboratories, received research fellowships from Amgen and The Howard Hughes Medical Institute, and published in peer-reviewed journals, including Science.Publicly announced deals:-$50M royalty monetization with Sagard Healthcare for additional Jemperli royalties (2024)-License agreement with Centessa for BDCA2 modulator portfolio (2023)-Equity investment in VISEN as part of its $150M Series B financing (2021)-Exclusive distribution agreement with Biopharma-MEA for Oxbryta® in GCC region (2020)-$375M research collaboration and option and license agreement with Syros (2019)-$127M license agreement with Roche for inclacumab (2018)-$303M option and license agreement with CrystalGenomics for CG'806 (2016)-Academic research collaboration agreement with Moffitt Cancer Center for epigenetic inhibitors (2015)-Drug discovery partnership with Laxai Avanti Life Sciences for epigenetic inhibitors (2015)

Nghi Nguyen's Current Company Details
AnaptysBio

Anaptysbio

View
Vice President, Corporate Development at AnaptysBio
Nghi Nguyen Work Experience Details
  • Anaptysbio
    Vice President, Corporate Development
    Anaptysbio Sep 2023 - Present
    San Diego, California, Us
    AnaptysBio is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics. It is developing immune cell modulators, including two checkpoint agonists in clinical-stage development, for autoimmune and inflammatory disease.
  • Medikine, Inc.
    Vice President, Head Of Corporate Development
    Medikine, Inc. Nov 2021 - Jun 2023
    Menlo Park, Us
    Medikine is a biotech with a mission to transform the discovery of oncology, autoimmune disorder and infectious disease therapeutics by employing a versatile drug discovery platform that generates modular “PEPTIKINES”- peptide mimetics of cytokines that are smaller in molecular size than, and structurally unrelated to, the natural cytokines they emulate.Responsibilities:-Shape and execute corporate strategy initiatives to grow platform and pipeline-Drive deal sourcing, due diligence, negotiation, and execution of transactions-Lead corporate communications
  • Ascendis Pharma A/S
    Director, Head Of Business Development And Alliance Management
    Ascendis Pharma A/S Sep 2020 - Oct 2021
    Hellerup, Capital Region Of Denmark, Dk
    Ascendis is applying its TransCon platform to build a leading biopharma company focused on making a meaningful difference in patients’ livesResponsibilities:• Chaired BD Leadership Committee and engage with CEO, CFO, CLO, SVP of Research, and VP of Strategy and Program Management to develop and execute overall BD strategy• Drove efforts to evaluate buy-side and prioritize sell-side opportunities for partnering and led all negotiation and contracting• Formalized, hired, and built alliance management function to support joint venture with Vivo Capital
  • Global Blood Therapeutics
    Associate Director, Corporate Development
    Global Blood Therapeutics Apr 2016 - Sep 2020
    South San Francisco, California, Us
    GBT is a commercial-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. Responsibilities: •Led annual long-range planning, P&L forecasting, valuation, and takeover defense advisory work with JPMorgan, Centerview, and Cravath•Sourced buy-side opportunities, led diligence, supported termsheet negotiation and contracting Past Project(s):•Drove New Opportunities Assessment effort with Chief Scientific Officer and Chief Medical Officer to identify new molecular targets in hemoglobinopathies and benign hematology for R&D
  • Aptose Biosciences, Inc.
    Manager, Business Development And Corporate Strategy
    Aptose Biosciences, Inc. Sep 2014 - Apr 2016
    San Diego, California, Us
    Aptose Biosciences is a science-driven biotechnology company advancing first-in-class therapeutics to treat hematologic malignancies, such as acute myeloid leukemia (AML) and high-risk myelodysplastic syndromes (MDS)Responsibilities: • Drove identification and due diligence of external opportunities• Supported negotiations of three agreements: one MSA and two in-licensing agreements• Synthesized scientific, clinical, and commercial competitive intelligence to support decision making• Built valuation and market revenue models for strategic planning and portfolio management
  • L'Oréal
    Group Leader, Global Technology Incubator
    L'Oréal Dec 2012 - Sep 2014
    Paris, Fr
    The L'Oréal Group is the largest cosmetics company and the Technology Incubator, a worldwide Research & Innovation team, creates and launches devices and tools that disrupt the global business of beautyResponsibilities:• Developed three-year planning of technology programs and product pipelines• Sourced, structured and negotiated the first facial tracking partnership that won L'Oreal the title of Fast Company's 50 Most Innovative Companies in 2014• Presented prototypes to global C-level executives and Vice Chairman of the Board of Directors
  • Wedbush Securities
    Investment Banking Analyst
    Wedbush Securities Dec 2011 - Dec 2012
    Los Angeles, California, Us
    The Wedbush Life Sciences Investment Banking Group is focused on public and private biotechnology, specialty pharmaceutical, and medical technology companies at all stages of developmentResponsibilities:• Conducted market opportunity analysis, competitive landscape mapping, strategic positioning, product portfolio management, and financial modeling• Built multiple presentations for C-level executives and Board of Directors
  • Deloitte
    Summer Analyst
    Deloitte Jun 2010 - Sep 2010
    Worldwide, Oo
    Deloitte Recap LLC (formerly Recombinant Capital) provide advice and analysis related to corporate and product developments and alliance formations in the life sciences industryResponsibilities:• Constructed financial models to evaluate various stage-specific deal structures• Analyzed 500+ biopharma partnership and alliance contracts from 2005 to 2010 to determined best practices in termination clauses and R&D technology reversion provisions
  • Stanford University School Of Medicine
    Research Assistant
    Stanford University School Of Medicine Jan 2007 - Jun 2010
    Palo Alto, Ca, Us
    The Blau Lab studies stem cell biology in bioengineered nichesProject: Published work on muscle stem cell self-renewal in Science
  • Howard Hughes Medical Institute
    Summer Research Fellow
    Howard Hughes Medical Institute Jun 2007 - Sep 2007
    Chevy Chase, Maryland, Us
    The Moon Lab investigates Wnt signaling pathways that are involved in development and diseaseProject: Published work on post-traumatic gliogenesis in Stem Cells
  • Ucsf Benioff Children'S Hospital Oakland
    Research Assistant
    Ucsf Benioff Children'S Hospital Oakland Aug 2003 - Jan 2005
    Oakland, Ca, Us
    The Watson Lab studies gene therapy for inherited metabolic diseasesProject: Investigated cholesterol synthesis deficiency in Smith-Lemli-Opitz syndrome
  • Harvard Medical School
    Summer Research Intern
    Harvard Medical School Jun 2004 - Aug 2004
    Boston, Ma, Us
    The Rosen Lab studies bone morphogenetic proteins (BMPs) in musculoskeletal tissuesProject: Examined the role and function of BMP-3 in controlling chondrogenesis

Nghi Nguyen Skills

Biotechnology Strategy Start Ups Financial Modeling Market Research Life Sciences Due Diligence Strategic Partnerships Entrepreneurship Product Development Competitive Analysis Analysis Research Business Strategy Commercialization Valuation Analytics Genetics Licensing

Nghi Nguyen Education Details

  • Stanford University
    Stanford University
    Management Science
  • Stanford University
    Stanford University
    Biological Sciences

Frequently Asked Questions about Nghi Nguyen

What company does Nghi Nguyen work for?

Nghi Nguyen works for Anaptysbio

What is Nghi Nguyen's role at the current company?

Nghi Nguyen's current role is Vice President, Corporate Development at AnaptysBio.

What is Nghi Nguyen's email address?

Nghi Nguyen's email address is nn****@****gbt.com

What is Nghi Nguyen's direct phone number?

Nghi Nguyen's direct phone number is +141585*****

What schools did Nghi Nguyen attend?

Nghi Nguyen attended Stanford University, Stanford University.

What skills is Nghi Nguyen known for?

Nghi Nguyen has skills like Biotechnology, Strategy, Start Ups, Financial Modeling, Market Research, Life Sciences, Due Diligence, Strategic Partnerships, Entrepreneurship, Product Development, Competitive Analysis, Analysis.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.